Biotech companies
You know the science behind your asset. We help you understand what it will take to move it towards the clinic, connecting non-clinical, CMC, regulatory and clinical requirements before gaps become delays.
Whether you need early development guidance, additional specialist expertise or full clinical delivery, we shape our support around the next decision and the evidence needed to make it.
Small and mid-sized pharma
Growing portfolios can stretch internal teams across multiple assets, studies and specialist partners. We help make priorities, dependencies and delivery risks visible, so decisions remain connected across the portfolio.
Add one specialist function or a broader delivery team. We work within your established processes and provide the capacity you need without adding unnecessary management layers.
CRO partners
When a study requires regional reach, local expertise or early-phase infrastructure beyond your existing footprint, building it internally may not be practical. We help extend your delivery model where it matters.
We take responsibility for defined countries, functions or studies while working within your SOPs, systems, governance and sponsor relationship. Scope, responsibilities and escalation routes are agreed from the outset.